November 10, 2023

Bioniq Welcomes Matthijs Schellekens As Advisory Board Member

Bioniq is proud to announce that Matthijs Schellekens has joined its Advisory Board

In a significant move to expand its expertise in behavior change leveraging artificial intelligence, Bioniq is proud to announce that Matthijs Schellekens, former GM and Product Manager in Google’s Area 120, and with additional experience in Google and Google X, has joined its Advisory Board. Matthijs has led 0-1 products and teams in building consumer applications utilizing AI and specifically Large Language Models, experience which he will use to help Bioniq’s strategy to enhance its patented algorithm and integrate AI more deeply into the process of delivering personalized health solutions.

Matthijs Schellekens’s career in building products at Google has focused in recent years on the intersection of AI and health / behavior change. He led teams across Software Engineering, Product Management, UX Design, and Research, managing product strategy and partnerships with a keen focus on leveraging AI for transformative solutions.

His advisory role at Bioniq will involve guiding the strategic integration of AI into Bioniq’s systems, with a particular emphasis on maximizing the value extracted from blood test data. This will further personalize the health optimization process, making it more adaptive and predictive.

On joining Bioniq’s Advisory Board, Matthijs expressed his vision for AI health solutions : “Enhancing health proactively and shifting the focus from treatment to prevention is a very worthwhile pursuit and in this context I am excited to support Bioniq, a company that helps make it easy to find personalized and appropriate supplements for anyone. I firmly believe in harnessing personalized biochemical data and combining it with the latest AI capabilities to fundamentally change how we approach health and wellness. With Bioniq’s commitment to evolving their health solutions, I am confident we can make a profound impact on the lives of individuals on a global scale.”

About Bioniq

Bioniq is revolutionizing the health-tech industry with its AI-driven approach to personalized health. By leveraging detailed blood test data, Bioniq’s algorithm provides bespoke health insights and solutions, empowering individuals to take proactive steps towards optimal well-being.

For more information, please visit www.bioniq.com.

Choose your Bioniq

Read more

Well-being
January 28, 2025

Understanding Ferritin: The Key to Managing Your Iron Levels

If you often feel tired, weak, or struggle to focus, your ferritin levels might be to blame. But what exactly is ferritin, and why is it so important for your health? This comprehensive guide will answer those questions and explore how you can manage your ferritin levels effectively, including the role of supplementation.
Press
March 18, 2025

Manchester United’s Diogo Dalot Invests Over €1M in Bioniq, Joining Cristiano Ronaldo

London, February 25, 2025 – Bioniq, founded in 2019 and renowned for its personalized nutritional supplements based on blood biomarker data, is proud to announce that football star Diogo Dalot, right-back for Manchester United and the Portugal national team, has joined the company as an investor, contributing over €1 million. Dalot joins the global football icon Cristiano Ronaldo, who became a major investor in 2024, and brought Bioniq’s total valuation to $82 million. Dalot’s investment marks another milestone in Bioniq’s mission to make personalized health accessible to athletes and everyday individuals worldwide.
Press
January 14, 2025

Bioniq Launches Custom Supplement Product for Individuals with Special Health Needs

Already poised to reshape the global supplements market — projected to grow by 6.74% annually to reach $44.24 billion by 2029 — Bioniq is expanding its offerings with an ultimate solution tailored to the estimated 15% of the population with special health needs seeking personalized vitamins.